MedTrace Logo

Non-interventional Study With NOVOCART® Basic in Patients Treated for Cartilage Defects in the Knee With MAC

NCT03808623 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2020-04-02

No results posted yet for this study

Summary

Retrospective, multicenter, single arm, non-interventional study to assess the safety and Performance of NOVOCART Basic and the clinical outcome of MAC with NOVOCART Basic in patients treated for cartilage defects in the knee.

Conditions

  • Cartilage Diseases

Interventions

DEVICE

MAC with NOVOCART Basic

NOVOCART® Basic is a biphasic, collagen-based matrix to support the biological reconstruction of localized and full-thickness cartilage damages after treatment with bone marrow stimulation techniques (microfracture). The procedure is called matrix associated chondrogenesis (MAC). It is a single-step procedure. NOVOCART® Basic is tailored to fit the prepared defect size and is inserted in the defect area after microfracture. The NOVOCART® Basic device component is fully resorbed over a period of a few months as new reparative cartilage tissue is generated and integrated with the surrounding host tissue.

Sponsors & Collaborators

  • Aesculap AG

    collaborator INDUSTRY

  • Winicker Norimed GmbH

    collaborator INDUSTRY

  • Tetec AG

    lead INDUSTRY

Principal Investigators

  • Bernhard Waibl, MD · Cartilage Care

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-09
Primary Completion
2019-07-24
Completion
2019-07-24

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03808623 on ClinicalTrials.gov